These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2146784)
1. A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. Reinsmoen NL; Kaufman D; Matas A; Sutherland DE; Najarian JS; Bach FH Transplantation; 1990 Nov; 50(5):783-90. PubMed ID: 2146784 [TBL] [Abstract][Full Text] [Related]
2. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Reinsmoen NL; Matas AJ Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534 [TBL] [Abstract][Full Text] [Related]
4. The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression. Thomas J; Alqaisi M; Cunningham P; Carver M; Rebellato L; Gross U; Patselas T; Araneda D; Thomas F Transplantation; 1992 Feb; 53(2):247-58. PubMed ID: 1531393 [TBL] [Abstract][Full Text] [Related]
8. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. Reinsmoen NL; Jackson A; McSherry C; Ninova D; Wiesner RH; Kondo M; Krom RA; Hertz MI; Bolman RM; Matas AJ Transplantation; 1995 Dec; 60(12):1546-54. PubMed ID: 8545888 [TBL] [Abstract][Full Text] [Related]
9. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man. Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251 [TBL] [Abstract][Full Text] [Related]
10. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity. Jackson A; McSherry C; Butters K; Diko M; Almond PS; Matas AJ; Reinsmoen NL Hum Immunol; 1997 Jul; 55(2):148-53. PubMed ID: 9361966 [TBL] [Abstract][Full Text] [Related]
11. Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiation. Nagasaki K; Obara H; Xiong A; Kambham N; Strober S; Esquivel CO; Millan MT Transplantation; 2007 Sep; 84(5):619-28. PubMed ID: 17876275 [TBL] [Abstract][Full Text] [Related]
12. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Strober S; Benike C; Krishnaswamy S; Engleman EG; Grumet FC Transplantation; 2000 Apr; 69(8):1549-54. PubMed ID: 10836360 [TBL] [Abstract][Full Text] [Related]
13. Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells. Thomas JM; Carver FM; Cunningham PR; Olson LC; Thomas FT Transplantation; 1991 Jan; 51(1):198-207. PubMed ID: 1824804 [TBL] [Abstract][Full Text] [Related]
14. The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawal. Flechner SM; Kerman RH; Van Buren CT; Epps L; Kahan BD Transplantation; 1984 Dec; 38(6):685-91. PubMed ID: 6239415 [TBL] [Abstract][Full Text] [Related]
15. Effect of early cyclosporine levels on kidney allograft rejection. Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683 [TBL] [Abstract][Full Text] [Related]
16. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine. Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425 [TBL] [Abstract][Full Text] [Related]
17. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine. Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695 [TBL] [Abstract][Full Text] [Related]
18. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival. Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130 [TBL] [Abstract][Full Text] [Related]
19. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Kahan BD Transplantation; 1991 Feb; 51(2):338-42. PubMed ID: 1825242 [TBL] [Abstract][Full Text] [Related]
20. Kidney allograft survival in dogs treated with total lymphoid irradiation. Howard RJ; Sutherland DE; Lum CT; Lewis WI; Kim TH; Slavin S; Najarian JS Ann Surg; 1981 Feb; 193(2):196-200. PubMed ID: 6451205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]